LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Research Sorting Out Risk Genes for Brain Disorders

By LabMedica International staff writers
Posted on 09 Mar 2017
Print article
Image
Image
Using targeted gene sequencing in a large cohort population, researchers have discovered genes associated with higher risk of neurodevelopmental-disorders (NDDs), with some of those genes showing statistical biases for autism. The study provides new information about similarities and differences underlying various NDDs.

To identify and better understand gene-disrupting mutations related to NDDs, a team led by researchers of the laboratory of Evan Eichler, University of Washington Health Sciences/UW Medicine and Howard Hughes Medical Institute, conducted a large, international, multi-institutional study. More than 11,700 affected individuals and nearly 2,800 control subjects underwent targeted DNA sequencing of 208 suspected disease-risk genes, candidate genes that were chosen based on previously published studies. Samples were collected through the Autism Spectrum/Intellectual Disability 15-center network spanning 7 countries and 4 continents. An advantage of this collection is the ability to check back on a large fraction of cases in attempt to relate genetic results to clinical findings.

In their study population, the researchers associated 91 genes with risk of a NDD, including 38 genes not previously suspected. Based on some of the family studies, however, mutations even in two or more of the risk genes may not be necessary or sufficient to cause disease.

Of the 91 genes, 25 were linked with forms of autism without intellectual disability. The scientists also described a gene network that appeared to be related to high-functioning autism. Individuals with this form of autism have average to above average intelligence, but may struggle in learning to talk, interact socially, or manage anxiety and sensory overload. Additional findings suggest that less severe mutations may be behind autism that is not accompanied by intellectual disability. Also notable, although the overall numbers were low, was that several autism risk genes appeared predominantly in males, including some detected exclusively in males who had autism without intellectual impairment.

While observing that some genes were more closely associated with autism and others with intellectual or developmental impairments, the researchers found that most of the genes implicated were mutated in both conditions. This result reinforces previous studies indicating substantial overlap among NDDs in their underlying genetics and observable characteristics.

"Most of these genes are clearly risk factors for neurodevelopmental disorders in a broad sense," the researchers said, "But analysis of both the genetic and subsequent patient follow-up data did single out some genes with a statistical bias towards autism spectrum disorder, rather than an intellectual disability or developmental delay." By combining clinical and genetic data, the researchers observed patterns enabling them to begin to assess how some of the genes might function and how their disruption might lead to specific traits or symptoms.

The researchers also used Drosophila to investigate 21 genes to determine if any of the mutations disrupted a specific form of learning: habituation – growing accustomed to harmless stimuli. Problems with the neuronal mechanisms behind habituation are thought to account for some autism features, such as inability to filter sensory input. The Drosophila studies showed habituation deficits from several of the gene mutations under review, thereby providing additional evidence that they may have a role in cognitive function.

"The scientists are continuing this project and are eager to work with interested families," said University of Washington Prof. Raphael Bernier, clinical director of the Seattle Children's Autism Center. Families can contact the project team at rablab@uw.edu.

The study, by Stessman HAF et al, was published online February 13, 2017, in the journal Nature Genetics.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The novel test uses an existing diagnostic procedure as its basis to target the Epstein Barr Virus (Photo courtesy of 123RF)

Blood Test Measures Immune Response to Epstein-Barr Virus in MS Patients

Multiple sclerosis (MS) is a chronic neurological condition for which there is currently no cure. It affects around three million people globally and ranks as the second most common cause of disability... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: Insulin proteins clumping together (Photo courtesy of Jacob Kæstel-Hansen)

AI Tool Detects Tiny Protein Clumps in Microscopy Images in Real-Time

Over 55 million individuals worldwide suffer from dementia-related diseases like Alzheimer's and Parkinson's. These conditions are caused by the clumping together of the smallest building blocks in the... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more